vs
Orthofix Medical Inc.（OFIX）与Gentherm Inc（THRM）财务数据对比。点击上方公司名可切换其他公司
Gentherm Inc的季度营收约是Orthofix Medical Inc.的1.7倍（$382.8M vs $219.9M），Gentherm Inc净利率更高（0.8% vs -1.0%，领先1.8%），Gentherm Inc同比增速更快（8.5% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $6.7M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 3.7%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
金瑟公司（原阿梅里贡）是一家美国热管理技术企业，为汽车行业研发出了全球首款热电调温座椅系统——气候控制座椅系统。该系统于1999年率先被福特汽车采纳，作为选装配置搭载在2000款林肯领航员上，如今已应用于福特、通用、丰田（雷克萨斯）、起亚、现代、日产（英菲尼迪）等车企的50余款车型。
OFIX vs THRM — 直观对比
营收规模更大
THRM
是对方的1.7倍
$219.9M
营收增速更快
THRM
高出6.5%
2.0%
净利率更高
THRM
高出1.8%
-1.0%
自由现金流更多
OFIX
多$10.1M
$6.7M
两年增速更快
OFIX
近两年复合增速
3.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $382.8M |
| 净利润 | $-2.2M | $3.0M |
| 毛利率 | 71.1% | 23.7% |
| 营业利润率 | 0.2% | 4.6% |
| 净利率 | -1.0% | 0.8% |
| 营收同比 | 2.0% | 8.5% |
| 净利润同比 | 92.4% | -80.5% |
| 每股收益（稀释后） | $-0.05 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXTHRM
| Q4 25 | $219.9M | $382.8M | ||
| Q3 25 | $205.6M | $386.9M | ||
| Q2 25 | $203.1M | $375.1M | ||
| Q1 25 | $193.6M | $353.9M | ||
| Q4 24 | $215.7M | $352.9M | ||
| Q3 24 | $196.6M | $371.5M | ||
| Q2 24 | $198.6M | $375.7M | ||
| Q1 24 | $188.6M | $356.0M |
净利润OFIXTHRM
| Q4 25 | $-2.2M | $3.0M | ||
| Q3 25 | $-22.8M | $14.9M | ||
| Q2 25 | $-14.1M | $477.0K | ||
| Q1 25 | $-53.1M | $-128.0K | ||
| Q4 24 | $-29.1M | $15.3M | ||
| Q3 24 | $-27.4M | $16.0M | ||
| Q2 24 | $-33.4M | $18.9M | ||
| Q1 24 | $-36.0M | $14.8M |
毛利率OFIXTHRM
| Q4 25 | 71.1% | 23.7% | ||
| Q3 25 | 72.2% | 24.6% | ||
| Q2 25 | 68.7% | 23.9% | ||
| Q1 25 | 62.8% | 24.4% | ||
| Q4 24 | 69.0% | 24.4% | ||
| Q3 24 | 68.7% | 25.5% | ||
| Q2 24 | 67.8% | 25.7% | ||
| Q1 24 | 67.5% | 24.9% |
营业利润率OFIXTHRM
| Q4 25 | 0.2% | 4.6% | ||
| Q3 25 | -8.3% | 6.2% | ||
| Q2 25 | -7.9% | 6.4% | ||
| Q1 25 | -25.2% | 4.8% | ||
| Q4 24 | -5.3% | 6.7% | ||
| Q3 24 | -9.6% | 8.7% | ||
| Q2 24 | -12.5% | 8.8% | ||
| Q1 24 | -15.6% | 5.1% |
净利率OFIXTHRM
| Q4 25 | -1.0% | 0.8% | ||
| Q3 25 | -11.1% | 3.9% | ||
| Q2 25 | -6.9% | 0.1% | ||
| Q1 25 | -27.4% | -0.0% | ||
| Q4 24 | -13.5% | 4.3% | ||
| Q3 24 | -13.9% | 4.3% | ||
| Q2 24 | -16.8% | 5.0% | ||
| Q1 24 | -19.1% | 4.2% |
每股收益（稀释后）OFIXTHRM
| Q4 25 | $-0.05 | $0.08 | ||
| Q3 25 | $-0.57 | $0.49 | ||
| Q2 25 | $-0.36 | $0.02 | ||
| Q1 25 | $-1.35 | $0.00 | ||
| Q4 24 | $-0.76 | $0.48 | ||
| Q3 24 | $-0.71 | $0.51 | ||
| Q2 24 | $-0.88 | $0.60 | ||
| Q1 24 | $-0.95 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $160.8M |
| 总债务越低越好 | — | $189.0M |
| 股东权益账面价值 | $450.0M | $720.3M |
| 总资产 | $850.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资OFIXTHRM
| Q4 25 | $82.0M | $160.8M | ||
| Q3 25 | $62.9M | $154.3M | ||
| Q2 25 | $65.6M | $128.3M | ||
| Q1 25 | $58.0M | $163.1M | ||
| Q4 24 | $83.2M | $134.1M | ||
| Q3 24 | $30.1M | $150.6M | ||
| Q2 24 | $26.4M | $123.5M | ||
| Q1 24 | $27.0M | $125.1M |
总债务OFIXTHRM
| Q4 25 | — | $189.0M | ||
| Q3 25 | $157.2M | $189.0M | ||
| Q2 25 | $157.0M | $209.0M | ||
| Q1 25 | $156.9M | $262.0M | ||
| Q4 24 | $157.0M | $220.1M | ||
| Q3 24 | $118.5M | $222.1M | ||
| Q2 24 | $118.0M | $222.1M | ||
| Q1 24 | $118.2M | $222.2M |
股东权益OFIXTHRM
| Q4 25 | $450.0M | $720.3M | ||
| Q3 25 | $442.5M | $717.9M | ||
| Q2 25 | $458.3M | $699.7M | ||
| Q1 25 | $458.3M | $646.5M | ||
| Q4 24 | $503.1M | $616.9M | ||
| Q3 24 | $525.9M | $660.7M | ||
| Q2 24 | $546.0M | $640.3M | ||
| Q1 24 | $570.3M | $647.1M |
总资产OFIXTHRM
| Q4 25 | $850.6M | $1.4B | ||
| Q3 25 | $832.6M | $1.4B | ||
| Q2 25 | $837.2M | $1.4B | ||
| Q1 25 | $823.1M | $1.3B | ||
| Q4 24 | $893.3M | $1.2B | ||
| Q3 24 | $867.9M | $1.3B | ||
| Q2 24 | $882.0M | $1.2B | ||
| Q1 24 | $906.0M | $1.3B |
负债/权益比OFIXTHRM
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.36× | 0.26× | ||
| Q2 25 | 0.34× | 0.30× | ||
| Q1 25 | 0.34× | 0.41× | ||
| Q4 24 | 0.31× | 0.36× | ||
| Q3 24 | 0.23× | 0.34× | ||
| Q2 24 | 0.22× | 0.35× | ||
| Q1 24 | 0.21× | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $29.0M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $6.7M |
| 自由现金流率自由现金流/营收 | 7.6% | 1.7% |
| 资本支出强度资本支出/营收 | 4.9% | 5.8% |
| 现金转化率经营现金流/净利润 | — | 9.70× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $61.1M |
8季度趋势，按日历期对齐
经营现金流OFIXTHRM
| Q4 25 | $27.7M | $29.0M | ||
| Q3 25 | $12.4M | $56.1M | ||
| Q2 25 | $11.6M | $45.0M | ||
| Q1 25 | $-18.4M | $-13.3M | ||
| Q4 24 | $23.7M | $36.6M | ||
| Q3 24 | $11.7M | $46.3M | ||
| Q2 24 | $9.0M | $37.1M | ||
| Q1 24 | $-18.6M | $-10.3M |
自由现金流OFIXTHRM
| Q4 25 | $16.8M | $6.7M | ||
| Q3 25 | $2.5M | $46.5M | ||
| Q2 25 | $4.5M | $36.2M | ||
| Q1 25 | $-25.1M | $-28.2M | ||
| Q4 24 | $15.2M | $13.6M | ||
| Q3 24 | $6.3M | $26.6M | ||
| Q2 24 | $-360.0K | $17.8M | ||
| Q1 24 | $-29.1M | $-21.6M |
自由现金流率OFIXTHRM
| Q4 25 | 7.6% | 1.7% | ||
| Q3 25 | 1.2% | 12.0% | ||
| Q2 25 | 2.2% | 9.6% | ||
| Q1 25 | -13.0% | -8.0% | ||
| Q4 24 | 7.0% | 3.9% | ||
| Q3 24 | 3.2% | 7.2% | ||
| Q2 24 | -0.2% | 4.7% | ||
| Q1 24 | -15.4% | -6.1% |
资本支出强度OFIXTHRM
| Q4 25 | 4.9% | 5.8% | ||
| Q3 25 | 4.8% | 2.5% | ||
| Q2 25 | 3.5% | 2.4% | ||
| Q1 25 | 3.5% | 4.2% | ||
| Q4 24 | 4.0% | 6.5% | ||
| Q3 24 | 2.7% | 5.3% | ||
| Q2 24 | 4.7% | 5.2% | ||
| Q1 24 | 5.6% | 3.2% |
现金转化率OFIXTHRM
| Q4 25 | — | 9.70× | ||
| Q3 25 | — | 3.75× | ||
| Q2 25 | — | 94.43× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.39× | ||
| Q3 24 | — | 2.90× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
THRM
| Climate Control Seats | $200.9M | 52% |
| Lumbar And Massage Comfort Solutions | $58.5M | 15% |
| Climate Control Interiors | $50.3M | 13% |
| Other Automotive | $27.6M | 7% |
| Valve Systems | $24.1M | 6% |
| Medical Segments | $13.9M | 4% |
| Climate And Comfort Electronics | $7.4M | 2% |
